Connect public, paid and private patent data with Google Patents Public Datasets

Implantable bioabsorbable article

Info

Publication number
WO1992010218A1
WO1992010218A1 PCT/US1991/008972 US9108972W WO1992010218A1 WO 1992010218 A1 WO1992010218 A1 WO 1992010218A1 US 9108972 W US9108972 W US 9108972W WO 1992010218 A1 WO1992010218 A1 WO 1992010218A1
Authority
WO
Grant status
Application
Patent type
Prior art keywords
bioabsorbable
article
material
implantable
matrix
Prior art date
Application number
PCT/US1991/008972
Other languages
French (fr)
Inventor
Byron Kent Hayes
Original Assignee
W.L. Gore & Associates, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/148Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C8/00Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
    • A61C8/0003Not used, see subgroups
    • A61C8/0004Consolidating natural teeth
    • A61C8/0006Periodontal tissue or bone regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0077Special surfaces of prostheses, e.g. for improving ingrowth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2/2846Support means for bone substitute or for bone graft implants, e.g. membranes or plates for covering bone defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/0032Use of preparations for dental root treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/34Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/06Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • A61L31/10Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00004(bio)absorbable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/08Accessories or related features not otherwise provided for
    • A61B2090/0815Implantable devices for insertion in between organs or other soft tissues
    • A61B2090/0816Implantable devices for insertion in between organs or other soft tissues for preventing adhesion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004The prosthesis made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30032The prosthesis made from materials having different values of a given property at different locations within the same prosthesis differing in absorbability or resorbability, i.e. in absorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30062(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/30199Three-dimensional shapes
    • A61F2002/30224Three-dimensional shapes cylindrical
    • A61F2002/30235Three-dimensional shapes cylindrical tubular, e.g. sleeves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063Three-dimensional shapes
    • A61F2230/0069Three-dimensional shapes cylindrical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2240/00Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2240/001Designing or manufacturing processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/003Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in adsorbability or resorbability, i.e. in adsorption or resorption time
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067Means for introducing or releasing pharmaceutical products into the body

Abstract

An implantable bioabsorbable article for the separation and regeneration of tissue at a tissue defect site. The article comprises a fibrous matrix laminarly affixed to one surface of a cell-barrier sheet material. When implanted it allows ingrowth of tissue into the fibrous matrix side of the material; simultaneously the tissue to be regenerated at the tissue defect site is separated from the ingrowing tissue by the cell-barrier sheet material. A method for making the implantable bioabsorbable article is also described.

Description

IMPLANTABLE BIOABSORBABLE ARTICLE

FIELD OF THE INVENTION

This invention relates to an implantable bioabsorbable article for use as a mammalian-cell-barrier to aid in the regeneration of tissue. BACKGROUND OF THE INVENTION

A preferred technique to promote the regeneration of mammalian tissue is accomplished by the separation and isolation of a particular type of tissue to be regenerated from other competing undesirable tissues through the use of a biocompatible barrier material. This concept is known as guided tissue regeneration and was described in an article by J. Gottlow, et al . , titled "New Attachment Formation in the Human Periodontiu by Guided Tissue Regeneration" (Journal of Clinical Periodontology, 1986; Vol. 13, pp. 604-616). The function of the barrier material is to substantially preclude the movement of tissue cells through the thickness of the material and consequently limit the varieties of cell types at the treatment site. This function is combined with the requirement that the material maintain sufficient space adjacent to the defect so as to allow for the regeneration of the desirable tissue into that space. The preservation of space between the surface of the defect and the desired contours of the subsequently regenerated surface is necessary in order to allow for the regeneration of tissues into that space. Specific periodontal structures which may be regenerated in this fashion are the periodontal ligament, bone and cementum. The barrier material allows propagation of bone and periodontal ligament cells by precluding epithelial cells and gingival connective tissue cells which are believed to propagate at a greater rate. This concept may be useful for other applications where separation of specific cell varieties is desirable such as, for example, nerve repair and nerve guidance applications, bone regeneration and prevention of soft tissue adhesions, particularly those of the peritoneum.

A description of a bioabsorbable tubular device useful for nerve repair is provided in U.S. Patent 4,870,966 to Dellon, et al .

Additionally, it has been proposed that the mechanical stability of the blood clot which forms in the defect space adjacent to the tooth root after periodontal surgery may be important to the regeneration process ( ikesjo et al., 1990; J. Periodontal., Vol. 61, 559-563). Therefore a material which can become infiltrated with blood clot and thus form a connection between the material and the adjacent gingival flap may add to the mechanical stability of the wound.

One commercially available material that provides a cell-barrier for periodontal tissue regeneration is the GORE-TEX® Periodontal Material. This polytetrafluoroethylene (PTFE) material serves as a cell-barrier between the gingiva and a periodontal defect and is intended to preserve necessary space between the surface of the defect and the desired contours of the subsequently regenerated surface. The GORE-TEX Periodontal Material is made of porous expanded PTFE having a microstructure of nodes interconnected by fine fibrils. This commercially available material is not of laminar construction and its porosity is generally uniform through the thickness of the material. One portion of the total surface area of the GORE-TEX Periodontal Material has a porous structural surface that becomes infiltrated with blood clot and ingrown with fibrous connective tissue, thereby inhibiting epithelial migration. The remaining portion of the surface area has a cell-barrier structure of low porosity for isolating the overlying gingival connective tissue from the underlying defect. It is not bioabsorbable and is typically removed in a subsequent surgical procedure. There have been previous attempts to produce suitable surgical barriers from bioabsorbable materials. A 70 micron thick membrane solvent-cast from bioabsorbable polylactic acid, having no inherent porosity or tissue cell permeability, was tested in periodontal applications as a cell-barrier material for exclusion of epithelium and gingival connective tissue during healing (I. Magnusson, et al., "New Attachment Formations Following Controlled Tissue Regeneration Using Biodegradable Membranes", J. Periodontal January, 1988 pp. 1-6). Tests showed some new formation of cementum and bone. Reproductions of this material demonstrated poor surgical handling characteristics due to its thin friable construction and also proved to be difficult to suture because of its brittleness. This material makes no provision for tissue ingrowth on either of its surfaces. • j-

Another material that is commercially available for use in guided tissue regeneration is Vicryl® Periodontal Mesh available from Johnson & Johnson. The Vicryl Periodontal Mesh is comprised of woven fibers made from a bioabsorbable copolymer of about 90% glycolide and 10% lactide. Studies have shown that the Vicryl Periodontal Mesh has had some success as a barrier material that provides for tissue regeneration (Fleisher et al., "Regeneration of lost attachment apparatus in the dog using Vicryl Absorbable Mesh", International Journal of Periodontics and Restorative Dentistry 2/1988 pp 45-55). Difficulties with this conventional woven construction include its inferior ability to maintain space adjacent to the defect and its marginal effectiveness as a tissue barrier because of the inherent porosity of the woven structure. This material is a single layer material of woven construction that is intended to both promote tissue ingrowth and simultaneously serve as a tissue barrier. As these are somewhat contradictory objectives for a single layer material of woven construction having a degree of inherent porosity, ingrowth can only be made to occur at the expense of the barrier function. The effectiveness of this material is therefore a compromise between the material's ability to allow for tissue ingrowth and the requirement to simultaneously function as a tissue barrier.

There remains a need for a bioabsorbable material for use as an effective cell-barrier that allows for tissue attachment on at least one surface, adds to the stability of the healing wound through blood infiltration and coagulation into the material, substantially precludes passage of tissue cells through the material, possesses adequate rigidity to ensure preservation of the desired space proximal to the defect and has acceptable surgical handling properties and strength. Bioabsorbable materials are herein defined as those materials of either synthetic or natural origin which when placed into a living body are degraded through either enzymatic, hydrolytic or other chemical reactions, into byproducts which are either integrated into or expelled from the body. Cells and tissue are herein defined as mammalian cells and mammalian tissue. - -

SUMMARY OF THE INVENTION

This invention provides an implantable bioabsorbable article useful for the separation and regeneration of mammalian tissue, comprising a fibrous matrix affixed in laminar relationship to at least one side of a cell-barrier sheet material wherein the fibrous matrix is a porous material that allows the infiltration of blood clot and the ingrowth of tissue, and the cell-barrier sheet material substantially precludes the passage and further ingrowth of tissue. A preferred embodiment provides a fibrous matrix laminarly affixed to both sides of the cell-barrier sheet material. The invention may be made in either a flat planar form or alternatively in a tubular form for use in, for example, nerve repair and nerve guidance applications. Preferred bioabsorbable materials include polyglycolic acid fibers for the fibrous matrix and a copolymer of polylactic acid and polyglycolic acid for the cell-barrier sheet material.

A method for making the implantable bioabsorbable article of the present invention is also provided.

BRIEF DESCRIPTION OF THE DRAWINGS

Figure 1 is a perspective view of the implantable bioabsorbable article of the present invention having a fibrous matrix laminarly affixed to one side of a cell-barrier sheet material.

Figures 2A, 2B and 2C are cross sectional views of the implantable bioabsorbable article of Figure 1 wherein the fibrous matrix is of unorganized configuration. Figure 3 is a cross sectional view of the implantable bioabsorbable article of Figure 1 wherein the fibrous matrix is of organized configuration.

Figures 4A, 4B and 4C are cross sectional views of an alternative embodiment of the present invention having a fibrous matrix laminarly affixed to both sides of a cell-barrier sheet material.

Figures 5A, 5B and 5C show the preferred periodontal repair embodiment of the present invention incorporating a bioabsorbable suture into its construction. Figure 6 is a cross section of a periodontal defect showing the preferred periodontal repair embodiment of the present invention.

Figure 7 shows a schematic drawing of the process of making the implantable bioabsorbable article of the present invention. Figure 8 shows a schematic drawing of a process of making the alternative embodiment having a fibrous matrix affixed to both sides of the cell-barrier sheet material.

Figures 9 and 10 show a schematic drawings of two alternative processes of making the implantable material of the present invention. Figure 11 shows the implantable bioabsorbable article of the present invention formed into a tube useful for repairs such as vascular and nerve guide repair.

Figure 12 shows a cross section of an alternative tubular embodiment.

DETAILED DESCRIPTION OF THE INVENTION

Reference will now be made in detail to the present invention, examples of which are illustrated in the drawings.

The basic structure of the article is shown in Figure 1, comprising a composite material having a fibrous matrix 10 laminarly affixed to a cell-barrier sheet material 12. The fibrous matrix and cell-barrier sheet material are designed to be superimposed and affixed together in a laminar fashion so that the implantable bioabsorbable article has one surface that provides an open structure of void spaces capable of accommodating tissue ingrowth while the opposite surface provides a cell-barrier.

The cross section of Figure 2A shows the implantable bioabsorbable article in further detail. The cell-barrier sheet material 12 has two opposing surfaces, designating the first opposing surface 13 and the second opposing surface 15. The fibrous matrix 10 is laminarly affixed to the first opposing surface 13 of the cell- barrier sheet material 12. By laminarly affixed is meant that the fibrous matrix 10 is attached directly to the surface of the cell- barrier sheet material 12 as shown by Figure 2A, or extends through the first opposing surface 13 as shown by the cross section of Figure 2B, or extends through the first surface 13 to the second surface 15 -ό-

as shown by the cross section of Figure 2C. Affixing is preferably accomplished by superimposing the fibrous matrix H) on the first opposing surface 13 of the cell-barrier sheet material 12 while the cell-barrier sheet material 11 is in a softened or even liquid state as will be further described. Alternatively a bioabsorbable adhesive may be used to bond and thereby laminarly affix the fibrous matrix K) to the first opposing surface 13 of the cell-barrier sheet material 12.

The fibrous matrix 10 comprises a mesh of fibers in either a random, unorganized configuration 14 as shown by the cross sections of Figures 2A, 2B and 2C, or alternatively the fibrous matrix comprises an organized fabric configuration 16 such as a fabric capable of supporting tissue ingrowth as shown by the cross section of Figure 3. The organized configuration 16 is a fabric configuration which may be comprised of threads, yarns, nets, knits, weaves, laces, or felts of fibers. Alternatively, the fibrous matrix may be comprised of an open cell foam structure that will allow tissue ingrowth. Regardless of construction, the fibrous matrix must be sufficiently open to allow infiltration of blood and subsequent interconnection of ingrowing tissue through the open spaces existing between the fibers that comprise the matrix. In general, any bioabsorbable material having an open structure capable of tissue ingrowth may be suitable as the fibrous matrix so long as the mechanical properties and rate of bioabsorption are also appropriate for the intended application. The thickness of these fibrous matrix materials may vary depending on the end use application.

The cell-barrier sheet material is typically non-porous but may also be porous so long as the pore sizes are small enough to substantially preclude cell passage and ingrowth. Such a porous cell- barrier sheet material may be advantageous for certain applications, for example, where passage of nutrients or gasses across the material may be important.

The ability of an article to allow tissue ingrowth or conversely to substantially preclude cell passage and ingrowth can be determined by implanting the article into a dog and allowing time for healing to occur. The article and adjacent tissue complex should be harvested and histologically evaluated after three weeks, before substantial -?-

bioabsorption of the article has occurred. When evaluated, if mammalian cells, fibrous connective tissue cells or extracellular matrix, or collagen, have invaded the spaces between adjacent structures within the fibrous matrix, resulting in a connection between the article and adjacent tissue, the article is deemed capable of allowing tissue ingrowth and incapable of substantially precluding cell passage and ingrowth.

The cell-barrier sheet material should be composed of a synthetic bioabsorbable material such as, for example, polycaprolactone, poly p- dioxanone, trimethylene carbonate, polyglycolic acid (PGA) or polylactic acid (PLA) or copolymers thereof. For periodontal applications, a preferred material is a copolymer of PLA and PGA, with preferred mixtures ranging from about 85% PLA and 15% PGA to about 50% PLA and 50% PGA. The equal ratio copolymer can be expected to bioabsorb at the fastest rate. For a comparison of bioabsorption rates of these materials, see Lewis, Danny H., Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers, pp 1-41, Biodegradable Polymers As Drug Delivery Systems. Mark Chasin and Robert Langer (ed); Marcel Dekker, Inc., New York, NY, 1990. Copolymers of PLA and PGA are polymerized from appropriate proportions of lactide and glycolide which are cyclic dimers based on lactic acid and glycolic acid respectively. The lactic acid components of the lactide di er may be of either the d (dextrorotatory) or 1 (levorotatory) configuration or may be a mixture of the two configurational varieties (e.g., d,l lactide). Polymers containing mixtures of d,l lactides possess little or no polymeric crystallinity resulting in lessened rigidity and a relatively low glass transition temperature when compared with a more crystalline counterpart such as 1 lactide. The preferred periodontal repair embodiment for the cell-barrier sheet material component contains copolymers d,T lactide with glycolide which correspondingly provides minimal rigidity and a glass transition temperature conducive to subsequent thermal bonding of the embodiment incorporating a fibrous matrix on both sides of the barrier material. These copolymers bioabsorb through hydrolysis returning them to their original components which are subsequently expelled from or assimilated into the body. The in vivo longevity of a particular copolymer is a function of its molecular weight combined with the ratio of its lactide and glycolide components. In general, the rate of hydrolysis is decreased with increasing lactic acid composition. For periodontal applications, the fibers from which the fibrous matrix is constructed are preferably made of PGA in order to provide for bioabsorption of the matrix in a suitable time frame. Different fibers of the matrix may be comprised of different bioabsorbable polymers so that different fibers may be bioabsorbed at different rates. The implantable bioabsorbable article should be mechanically capable of successfully retaining sutures for the amount of time required for enough healing to render the sutures unnecessary. The implantable bioabsorbable article should also be pliable and formable and not be brittle or thick so that it is hard to suture or difficult to conform to the ideal contours desired at the defect site. The article must not be so flexible that it collapses into the defect space but rather maintains and protects that space for an adequate time to allow healing to occur. These mechanical characteristics have been achieved with the implantable bioabsorbable article of the present invention and are the result of the structural combination of the fibrous matrix laminarly affixed to the cell-barrier sheet material.

The cross section of Figure 4A describes a preferred alternative embodiment of the present invention wherein a fibrous matrix 10 is affixed to both opposing sides of a cell-barrier sheet material 12. As shown by the cross section of Figure 4B, one way to produce this embodiment is to laminarly affix together the exposed cell-barrier surfaces of two samples 41 and 42 of the implantable bioabsorbable article having a fibrous matrix attached to only one side of the cell- barrier sheet material. The laminar juncture of the two samples 41 and 42 is shown at 44-

Alternatively, as shown by the cross section of Figure 4C, it is possible to fold in half a single sample of the single-sided implantable bioabsorbable article with the surfaces of the cell- barrier material brought together and affixed. The fold is indicated at 43 and the laminarly affixed cell-barrier sheet material surface juncture is shown at 44- A method of affixing the cell-barrier sheet material surface will be described below.

As shown by Figure 5A, the implantable bioabsorbable article of the present invention may also be made so that it incorporates a bioabsorbable suture 50 to make the securing of the article to adjacent anatomical structures as simple as possible. This embodiment is considered to be at the present time the best mode of the present invention for periodontal repair. This embodiment is made most simply by placing a suture into the fold of the two-sided article described in Figure 4C. The cross section of Figure 5B shows this in detail. Other embodiments incorporating an affixed bioabsorbable suture are also possible. One such alternative embodiment is shown by Figure 5C wherein a portion 52 of the cell-barrier material 12 is not covered by the fibrous matrix 10 and that portion 52 of the article is folded around a length of suture 50. The coronal edge of the article as implanted is indicated at 54- Other methods of attaching a suture may be used, for example, interweaving the suture through the thickness of the article.

In an alternative embodiment, the fibrous matrix, the fibers, the cell-barrier material, or any combination thereof may also be impregnated with any single or combination of substances such as antibiotics, antimicrobials, growth factors, differentiation factors, cell attachment factors or other such therapeutic agents. Impregnation of the implantable bioabsorbable article with such a therapeutic agent involves simply coating the article with the agent or alternatively incorporating the agent into the material from which either the fibrous matrix or the cell-barrier is constructed. For example, the therapeutic agent may be included in the polymer and solvent solution from which the cell-barrier is subsequently made. The incorporation of a therapeutic agent into the material of the implantable bioabsorbable article in this fashion would result in the release of the therapeutic agent into the living body in which the article is implanted. The presence of such an impregnating therapeutic agent in the implantable bioabsorbable article can be determined by accepted analytical techniques involving extraction, solvation, or other isolation methods whereby the therapeutic agent may be separated from the material from which the implantable bioabsorbable article is constructed.

A typical application of the implantable bioabsorbable article is shown in the cross section of Figure 6. This figure illustrates the relationship of the implantable bioabsorbable article and adjacent anatomical structures immediately after the surgical placement of the article. The enamel tooth crown is indicated at 61 and the tooth root (dentin) is shown at 62. The periodontal ligament is indicated by 63, the supporting alveolar bone is shown by 64 and the ce entum is shown at 69. A periodontal defect exists at 65 wherein the cementum, the periodontal ligament and alveolar bone are missing from the void space also shown by 65. This void space 65 will typically become filled with blood clot during or shortly after surgery. The implantable bioabsorbable article is shown in cross section at 66. In this particular case, the embodiment shown is the article having a fibrous matrix material 10 affixed to both sides of the cell-barrier material 12. The implantable bioabsorbable article 66 is shown serving as a barrier between the periodontal defect 65 and adjacent gingival connective tissue 67 and gingival epithelium 68. This embodiment of the implantable bioabsorbable article is shown with an incorporated bioabsorbable suture 50 as previously described in Figures 5A and 5B. The suture 50 is shown attaching the implantable bioabsorbable article to the tooth root 62 by encircling the tooth root 62.

According to the preferred method of making the implantable bioabsorbable article, the process of laminarly affixing the fibrous matrix to the cell-barrier sheet material is accomplished by placing a fibrous matrix into a bioabsorbable polymer and solvent solution and applying pressure and heat to evaporate the solvent, the bioabsorbable polymer forming the cell-barrier sheet material as the solvent evaporates. The selection of the solvent and the fibrous matrix material should be coordinated so that the fibrous matrix material is not readily soluble in the solvent. A preferred polymer and solvent solution is that of a PLA and PGA copolymer in a solvent such as acetone. The use of PGA fibers for the fibrous matrix is a preferred combination as such fibers are not readily soluble in the acetone. As shown by Figure 7, the polymer and solvent solution 70 and fibrous matrix 10 are placed on a surface 72. capable of transferring - 1 / -

heat at a temperature above the boiling point of the solvent in order to evaporate the solvent. The heating surface 72 must possess suitable release properties to allow removal of the finished implantable bioabsorbable article without damage. Suitable heating surface materials include polytetrafluoroethylene (PTFE), fluorinated ethylene-propylene (FEP), and other materials having adequate temperature capability and having release properties.

The preferred process for producing the implantable bioabsorbable article of the present invention is as follows. The fibrous matrix 10 and the solution of bioabsorbable polymer and solvent 70 are introduced between two opposing release surfaces 72 and 74 which are then compressed together as indicated by arrows 76 while heat in excess of the boiling temperature of the solvent is applied from release surface 7£. The temperature should be higher than the boiling point of the solvent in order to assure rapid evaporation of the solvent within a few seconds. As a result of the rapid evaporation of the solvent, the fibrous matrix material is coated with the solvent carried polymer. Upon evaporation of the solvent, points of contact between adjacent fibers of the matrix are adhesively bonded. Simultaneously, the cell-barrier sheet material of the chosen bioabsorbable polymer or copolymer is deposited at the surface from which heat is applied. The resulting implantable bioabsorbable article is then removed from between the release surfaces.

To construct the two-sided embodiment shown by Figure 4B having a fibrous matrix on two the opposing surfaces of the cell-barrier sheet material, two implantable bioabsorbable articles are prepared as described above. The two implantable bioabsorbable articles are placed so that their cell-barrier surfaces face each other and are superimposed on each other laminarly as shown by Figure 8. Pressure and heat are applied at a temperature above the glass transition temperature of the barrier and below that of the fiber. This results in the two film surfaces adhering to one another to form a composite having a fibrous matrix on the two opposing surfaces of the cell- barrier sheet material. It is preferable to prepare the cell-barrier sheet materials with a PLA/PGA copolymer for the two-sided embodiment as the copolymer possesses a glass transition temperature between 40 and 60βC. The embodiment incorporating a suture is made as described in the previous paragraph with the addition of a length of bioabsorbable suture placed between the two sheets of implantable bioabsorbable material before the two sheets are affixed together, the ends of the suture extending beyond the affixed sheets. Alternatively and preferably, as shown by the cross sections of Figures 5A, 5B and 5C, a single layer of the implantable bioabsorbable article is folded in half so that the suture is captured within the fold.

Figure 9 describes a preferred process wherein compression 76 is applied by a traversing roller 93 instead of a flat compression surface. The process is essentially the same as described previously. Separate removable upper and lower FEP film release layers 91 and 92 may be used optionally to provide the necessary release characteristics. Figure 10 describes an alternative process useful for a continuous process of manufacturing the implantable bioabsorbable article wherein the bioabsorbable polymer and solvent solution are applied as a liquid 90 to the fibrous matrix 10 from a liquid dispensing means 97.. The fibrous matrix material 10 and applied bioabsorbable polymer solvent solution is fed between a heated roller 95 and an adjacent second roller 93.. The finished implantable bioabsorbable article 94 emerges from between the two compressing rollers 95 and 93.

As shown by Figure 11, tubular constructions of the implantable bioabsorbable article are also possible. These are made by rolling the finished article, made as previously described, around a mandrel to form a tube HO, and applying heat and pressure to the overlapping edge H of the tubular article in order to seal the overlapping edge to the underlying material H2.. Such a tubular article may have various implantable applications such as vascular repair and nerve repair. For nerve repair it is believed that excluding other tissues from the nerve repair site and constraining the healing nerve ends to prevent uncontrolled proliferation of nervous tissue are important factors in successful repair. It is also believed that retaining neurotropic and neurotrophic factors released by the distal nerve end, keeping these factors in the near vicinity of the proximal nerve end, is important in effecting successful nerve repair. The tubular - π-

article of the present invention is capable of providing for the exclusion of adjacent tissues from the nerve repair site, the containment of proliferating nervous tissue, and the retention of neurotropic and neurotrophic factors in the vicinity of the proximal nerve end. In a preferred embodiment for nerve repair, a tube is made by rolling the implantable bioabsorbable article into a tubular form as previously described with the fibrous matrix on the inner surface of the tube. It is preferred that the fibers be of an organized configuration in the form of parallel fibers on the inner surface of the tube oriented parallel to the longitudinal axis of the tube. It is believed that this fiber orientation provides a directional aid to the healing of the nerve between exposed nerve ends. The proximal and distal ends of a transected nerve will be placed in respective ends of this tubular article. These nerve ends may be abutted and sutured together, simply abutted, or left with a gap between the nerve ends when the tubular article is finally sutured or affixed by any suitable means to the nerve sheaths of the two nerve ends.

As shown by the cross section of Figure 12, an alternative tubular embodiment for nerve repair incorporates a layer of randomly configured fibrous matrix !£1 between the outer cell-barrier sheet material surface of the tube and the inner surface of parallel longitudinally oriented fibers 113. This construction offers improved crush resistance. The longitudinally oriented fibers H are shown in exaggerated diameter for clarity. In another tubular embodiment, an additional fibrous matrix may be used on the outer surface of the tube if attachment and stabilization of the surrounding external tissue is desired. A further embodiment may use a fibrous matrix outer tube surface with the cell-barrier sheet material forming the inner surface of the tube. The implantable bioabsorbable article of the present invention may also be useful for repair of bone defects and bone regeneration. Specific applications include endochondral bone, intermembranous or round bone, and long bone. The implantable bioabsorbable article may include a fibrous matrix laminarly affixed to only one side of the cell-barrier sheet material or will preferably include having a fibrous matrix affixed to both sides of the cell-barrier sheet material. The article intended for bone repair should be sufficiently rigid to guarantee the maintenance of space adjacent to a bone defect.

The implantable bioabsorbable article of the present invention may also be useful in the prevention of soft tissue adhesions, particularly those of the peritoneum including pelvic adhesions. The preferable implantable bioabsorbable article may include a fibrous matrix laminarly affixed to only one side of the cell-barrier sheet material or optionally will include having a fibrous matrix affixed to both sides of the cell-barrier sheet material. The fibrous matrix is useful for stabilizing the implantable bioabsorbable article at the desired location to prevent the occurrence of an adhesion at that location. The fibrous matrix is effective to the extent that the implantable bioabsorbable article can simply be placed at the desired location without the necessity of further securing means.

EXAMPLE 1

Approximately 40 to 45 milligrams of individual 30 micron diameter polyglycolic acid (PGA) 1 to 2 inch long fibers were air laid in a random configuration on the surface of a stainless steel screen. The fibers were fabricated from PGA homopolymer with an average molecular weight in excess of 100,000 daltons.

A first sheet of 0.020 inch thick FEP clear film £1 as shown by Figure 9, was placed onto a 4 x 4 inch horizontally oriented aluminum plate that had been heated to approximately 100βC. The fibrous matrix was removed from the stainless steel screen on which it had previously been fabricated, and was placed onto the first sheet of FEP film 9_1. Approximately 0.2 grams of 1:10 to 1:15 (w/w) solution of 1-lactide polymer in methylene chloride (dichloromethane) solvent was poured onto the center of the fibrous matrix. A second sheet of FEP clear film 92 was laid over the top of the fiber matrix and polymer and solvent combination. The resulting sandwich was immediately compression-rolled between the aluminum plate and a rolling cylinder of about 3.5 inches length and 2 inch diameter. The roller effectively applied a force of approximately eight pounds across its width, as shown by arrow 76.. Each compression roll process consisted -lo ¬

af an approximately 3 inch pass, of the roller across the surface of the fibrous matrix at a rate of approximately one complete cycle (2 passes) per second for a total of 2 minutes. The application of heat and pressure resulted in a finished implantable bioabsorbable article having a fibrous matrix laminarly affixed to one side of a cell- barrier sheet. Upon completion, the two FEP film sheets 91 and 9_2 and the finished implantable bioabsorbable article contained between the two FEP sheets was removed from the heated aluminum plate and allowed to cool under passive pressure applied by a 4" x 4" x 1" aluminum block.

After cooling, the two sheets of FEP were peelably removed from the finished implantable bioabsorbable article. The finished article was trimmed to 15 mm width and a 30 mm length. The article was folded in half across its 15mm width with the cell-barrier surface on the inside. A 5-0 PGA suture obtained commercially was trimmed of its needle and placed into the fold of the material as shown by Figures 5A nad 5B. The folded article was placed between two FEP film sheets and compressed by the roller and heated plate apparatus described by Figure 8. The plate temperature was 100βC. Pressure was again applied by traversing the roller back and forth over the article in one second cycles for a total period of 1 minute.

The finished implantable bioabsorbable article having an integrally attached suture was placed into a food grade pouch made of a polymer foil laminate. The pouch was sealed and gamma radiation sterilized at a total dosage of 2.0 Mrad.

EXAMPLE 2

The implantable bioabsorbable articles made and sterilized according to Example 1, each article incorporating an integrally attached suture as shown by Figures 5A and 5B, were implanted in dogs. The dog model has been used extensively for the testing of guided tissue regeneration techniques and materials (Caffesse et al . 1988, J. Periodontal Vol 59, 589-584; Claffey et al . 1989, J. Clin. Periodontal, Vol 16, 371-379).

At surgery, buccal and lingual full-thickness muco-periosteal -/ -

flaps were elevated from the first mandibular premolar to the mid portion of the mandibular first molar. Class II furcation defects were surgically created with high speed and hand instrumentation on the buccal aspects of the second and fourth mandibular premolars and the lingual aspects of the third mandibular premolars in four beagle dogs. The defects were created such that the roots were exposed between the mesial and distal line angles of the teeth and into but not through the furcation. The depth of the defects was approximately 4-6 millimeters. After the bone was removed, the exposed root surfaces were aggressively instrumented with high speed and hand instruments to remove any trace of the periodontal ligament and cementum. Reference notches were placed in the roots at the margins of the bony defects.

Defects were created in five separate mandibular premolar teeth per dog, the defects being intended to receive implantable bioabsorbable articles of the present invention. Each canine mandibular premolar tooth had two roots. The defects involved both roots of each of the five teeth for a total of ten roots potentially available for evaluation per dog. No sham operated controls were included in the experiment. It is well documented that surgical treatment of periodontal defect sites where no barrier material is placed will result in the formation of a long junctional epithelium and little or no regeneration of the periodontal attachment structures (Pfeifer et al., 1989, Int. J. Perio. Rest. Dent., Vol. 9, 263-273; Magnussen et al., 1988, J. Periodontal, Vol. 59, 1-6).

Each bioabsorbable article was first trimmed on the lateral and apical sides so that the material completely covered the defect and extended beyond the bony margins of the defect by at least 2 to 3 mm. The article was then positioned so that the coronal edge with the integrally attached suture was at the level of the cemento-enamel junction and completely covered the defect. The article was tied to the tooth with the integrally attached suture using a sling suture technique. The article was thus tightly adapted to the tooth surface along its coronal edge and draped over the surface of the bone. This created a protected space defined by the dimensions of the defect and the surface of the article which faced the defect. The muco- periosteal flaps were repositioned and the incisions closed using a combination of interrupted and vertical mattress sutures. Care was taken to make sure the membranes were completely covered by the soft tissue of the flaps.

The dogs received post operative oral hygiene care in the form of chlorhexidine (0.12%) flushes every other day starting seven days after surgery. Clinical parameters monitored during the healing period were gingival health, plaque index, exposure of material, gingival recession, and fragmentation or resorption of the exposed material . Sacrifice times for the animals were 2, 4, 8 and 12 weeks postoperative. At the time of sacrifice, the experimental teeth were removed en bloc and placed in 70% ethanol/30% distilled water fixative. After fixation, the teeth were infiltrated and embedded in poly(methylmethacrylate) and fifteen 6-8 micron thick bucco-lingual sections spanning the mesio-distal width of each tooth were cut for histological evaluation with a Reichart-Jung Polycut S sledge microtome. One section representing the greatest length of each root and located as close to the furcation as feasible was chosen for evaluation. The parameters measured on each root available for evaluation were:

Apical Epithelial Migration (EM) - the distance from the apical extent of the epithelium to the gingival margin. New Bone (NB) - the distance from the base of the instrumented root surface to the coronal extent of the new regenerated bone.

New Cementum (NC) - distance from the base of the instrumented root surface to the coronal extent of regenerated new cementum.

Defect Depth (DD) - the base of the instrumented root surface to the gingival margin (the area "at risk" for regeneration).

For EM, NB and NC, the distances were divided by DD and multiplied by 100 to obtain a percentage of the defect depth. The values for all available roots for each dog were averaged to obtain a single value for each dog. No adequate sections were obtained for three roots of the 4 week dog, 1 root of the 8 week dog and three roots of the 12 week dog. -ή-

Histological evaluation of the specimens revealed a mild chronic inflammatory response to the bioabsorbable membranes which was consistent with the response reported in the literature for this group of polymers (for example see Matlaga, B.F., and Salthouse, T.N., 1983; J. Biomed. Mat. Res. Vol. 19, 349-365). Fibrous connective tissue had infiltrated the fibrous matrix of the implantable bioabsorbable articles and there was clear interdigitation of collagen fibers between the ingrown tissue and the adjacent connective tissue of the flap. In all cases, the epithelium had migrated to a point at or very near the coronal border of the implantable bioabsorbable articles where the migration appeared to have been halted. In addition, at the two week time frame, the integrity of the implantable bioabsorbable article was substantially intact creating a barrier, as evidenced by a plane of separation between the flap tissue and the defect space. Also at the two week time frame the granulation tissue in the defect space had an immature appearance with a limited amount of extracellular matrix deposition and minimal differentiation of the tissue types.

At the remaining time frames, the integrity of the implantable bioabsorbable article was somewhat fragmented due to the resorption process. However, maturation of the tissues had occurred allowing measurement of the amount of newly regenerated bone and cementum. The resulting values are shown in Table I.

TABLE I

4 wk (N = 7) 8 wk (N = 9) 12 wk (N ■= 7)

EM = 31% ± 10% EM = 44% ± 13% EM = 52% ± 22%

NB - 27% ± 13% NB = 30% ± 13% NB = 32% ± 18%

NC = 65% ± 15% NC = 60% ± 11% NC = 54% ± 17%

Epithelial migration along the root surface can proceed at the rate of between 0.5 mm and 1.0 mm per day. If allowed to progress unimpeded, the epithelium would have migrated apically along either the outside of the implantable bioabsorbable articles or along the root surfaces. The data from this experiment show that the migration of the epithelium was limited by the fibrous connective tissue ingrowth and attachment to the implantable bioabsorbable articles. Concurrently, protection of the defect space from the epithelium and the gingival connective tissue by the implantable bioabsorbable articles allowed the regeneration of new bone in the defect space and new cementum on the root surfaces.

EXAMPLE 3

The preferred embodiment currently utilizes d,l PLA:PGA copolymer ratios between 50:50 and 85:15 for the cell-occlusive barrier forming material to provide a desirable in vivo bioabsorption rate for the periodontal application. Examples of the preferred embodiment were fabricated in accordance with the description of Example 1 with the following exceptions:

A. Approximately 38 to 42 milligrams of approximately 25 micrometer diameter PGA staple fibers were utilized in the fabrication of the fibrous matrix.

B. Individual samples were made utilizing d,l PLA:PGA copolymer ratios of either 85:15, 75:25, 60:40, and 50:50 for the cell- occlusive barrier forming material.

C. Each of the preferred embodiments utilizing d,l PLA:PGA copolymer ratios of either 85:15, 75:25, or 60:40 were fabricated with an approximately 1:3 to 1:5 (w/w) solution of the respective copolymer in acetone instead of in methylene chloride as described in Example 1.

EXAMPLE 4

A tubular article useful for tissue repair such as, for example, nerve repair, was constructed as follows.

A group of 1.5 inch long, 30 micron diameter PGA fibers were laid out approximately parallel in a strip about 0.5 inch wide, thus forming a fibrous matrix of organized configuration. 0.2 grams of about 1:5 (w/w) solution of 85:15 PLA:PGA copolymer in acetone was placed on this strip of fibers and heated and compressed in the apparatus of Figure 8 in the same manner as described in Example 1. The resulting implantable bioabsorbable article having a fibrous matrix of approximately parallel fibers was then trimmed to a rectangular shape. The article was then wrapped around a 3.5 mm inch diameter mandrel to form a tube with the fibers on the inside of the resulting tube and with the fibers approximately parallel to the longitudinal axis of the tube. The exposed edge of the implantable bioabsorbable tube was sealed to the outer surface of the tube through compression at a temperature of about 100βC.

EXAMPLE 5

A second tubular article was made according to the description of Example 4 with the addition of a layer of 20 milligrams of individual 30 micron diameter PGA fibers arranged in a random configuration. The additional fiber was first placed onto the release surface and the strip of approximately parallel fibers then placed on top of the layer of randomly configured fibers, and the same copolymer and solvent solution of Example 4 was placed on the matrix. Compression and heat was applied with the apparatus of Figure 9 in the same manner as described in Figure 1. The resulting article was fashioned into a tube in the same manner as described in Example 4.

Claims

I CLAIM:
1. An implantable bioabsorbable article useful for the separation and regeneration of mammalian tissue comprising: a) a bioabsorbable cell-barrier sheet material having first and second opposing surfaces; and b) a bioabsorbable fibrous matrix laminarly affixed to the first opposing surface of said bioabsorbable cell-barrier sheet material; wherein said fibrous matrix allows the ingrowth of tissue into the fibrous matrix and said bioabsorbable cell-barrier sheet material substantially precludes the passage and further ingrowth of tissue, thereby separating the ingrowth of tissue into the fibrous matrix adjacent to the first opposing surface of the cell-barrier sheet material from the regeneration of tissue adjacent to the second opposing surface of the cell-barrier sheet material .
2. An implantable bioabsorbable article according to Claim 1 wherein the bioabsorbable fibrous matrix is laminarly affixed to the first and second opposing surfaces of said bioabsorbable cell- barrier sheet material.
3. An implantable bioabsorbable article of Claim 1 wherein both the cell-barrier sheet material and the fibrous matrix are comprised of a synthetic bioabsorbable material selected from the group consisting of polylactic acid, polyglycolic acid, poly-P- dioxanone, trimethylene carbonate, polycaprolactone and copolymers thereof.
4. An implantable bioabsorbable article of Claim 3 wherein both the cell-barrier sheet material and the fibrous matrix are comprised of a copolymer of polylactic acid and polyglycolic acid.
5. An implantable bioabsorbable article of Claim 3 wherein the eel1- barrier sheet material is comprised of a copolymer of polylactic acid and polyglycolic acid and the fibrous matrix is comprised of polyglycolic acid fibers.
6. An implantable bioabsorbable article of Claim 5 wherein the eel 1 - barrier sheet material is comprised of a copolymer of about 50% polylactic acid and 50% polyglycolic acid. --u-
7. An implantable bioabsorbable article of Claim 5 wherein the cell- barrier sheet material is comprised of a copolymer of about 65% polylactic acid and 35% polyglycolic acid.
8. An implantable bioabsorbable article of Claim 5 wherein the cell- barrier sheet material is comprised of a copolymer of about 85% polylactic acid and 15% polyglycolic acid.
9. An implantable bioabsorbable article of Claim 1 wherein the fibrous matrix comprises a mesh of fibers in a random, unorganized configuration.
10. An implantable bioabsorbable article of Claim 1 wherein the bioabsorbable fibrous matrix comprises a mesh of fibers in an organized configuration selected from the group consisting of threads, yarns, nets, knits, weaves, laces and felts.
11. An implantable bioabsorbable article of Claim 1 wherein the bioabsorbable cell-barrier sheet material is porous having a pore size small enough to substantially preclude the passage and ingrowth of tissue.
12. The implantable bioabsorbable article of Claim 1 incorporating a suture affixed to the implantable bioabsorbable article.
13. The implantable bioabsorbable article of Claim 2 incorporating a suture affixed to the implantable bioabsorbable article.
14. The implantable bioabsorbable article of Claim 1 wherein the article has been fashioned into a tube having an inner and an outer surface wherein the cell-barrier sheet material forms the outer surface of the tube and the fibrous matrix forms the inner surface of the tube.
15. The implantable bioabsorbable article of Claim 14 wherein the tube has a longitudinal axis and the fibrous matrix is of organized configuration with the fibers approximately parallel to the longitudinal axis of the tube.
16. An implantable bioabsorbable article of Claim 1 wherein the implantable bioabsorbable article is impregnated with a substance selected from the group consisting of antibiotics, antimicrobials, growth factors, differentiation factors and cell attachment factors.
17. A method of using an implantable bioabsorbable article to regenerate periodontal tissue, said implantable bioabsorbable article having a fibrous matrix laminarly affixed to a cell- barrier sheet material, comprising: a) making an incision between gingival tissue and a periodontal defect; b) placing the implantable bioabsorbable article into the incision so that it separates the gingival tissue from the periodontal defect in order to allow for the regeneration of periodontal tissue without interference from the gingival tissue, the implantable bioabsorbable article being placed with the fibrous matrix adjacent to the gingival tissue; and c) closing the incision.
18. A method of using an implantable bioabsorbable article to repair a bone defect, said implantable bioabsorbable article having a fibrous matrix laminarly affixed to a cell-barrier sheet material, comprising: a) exposing the bone defect; b) placing the implantable bioabsorbable article over the bone defect to separate the bone defect from adjacent tissue and to preserve space proximal to the bone defect, the fibrous matrix being placed against the adjacent tissue; and c) securing the implantable bioabsorbable article over the bone defect.
19. A method of using an implantable bioabsorbable article to prevent a soft tissue adhesion from occurring on a soft tissue surface, said implantable bioabsorbable article having a fibrous matrix laminarly affixed to a cell-barrier sheet material, comprising placing the implantable bioabsorbable article on the soft tissue surface where the soft tissue adhesion is likely to occur.
20. A method of using an implantable bioabsorbable article to aid in repair of nerve ends, said implantable bioabsorbable article having a fibrous matrix laminarly affixed to a cell-barrier sheet material and said implantable bioabsorbable article being in the form of a tube having open ends, comprising: a) making an incision to expose the nerve ends; b) placing the nerve ends into the open ends of the tube; c) affixing the tube to the nerve ends by affixing means; and d) closing the incision. -λ -
21. A process for making an implantable bioabsorbable article having a fibrous matrix laminarly affixed to one side of a cell-barrier sheet material comprising steps of:
(a) forming a solution of at least one bioabsorbable polymer with a solvent;
(b) placing a fibrous matrix which is substantially insoluble in the solvent onto a first heated release surface;
(c) introducing the solution onto the fibrous matrix;
(d) compressing the fibrous matrix and solution between the first heated release surface and a second opposing release surface while heat is applied by the first heated release surface at a temperature above the boiling point of the solvent in order to evaporate the solvent; and
(e) releasing the compression and removing the implantable bioabsorbable article from between the first heatable release surface and the second opposing release surface.
22. A process according to Claim 21 wherein the second opposing release surface is a roller.
23. A process according to Claim 22 wherein the first heated release surface is a roller.
PCT/US1991/008972 1990-12-06 1991-12-02 Implantable bioabsorbable article WO1992010218A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US62286990 true 1990-12-06 1990-12-06
US622,869 1990-12-06

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE1991621587 DE69121587D1 (en) 1990-12-06 1991-12-02 An implantable bioabsorbable article
JP50294792A JPH06506366A (en) 1990-12-06 1991-12-02
EP19920902824 EP0560934B2 (en) 1990-12-06 1991-12-02 Implantable bioabsorbable article
CA 2094908 CA2094908C (en) 1990-12-06 1991-12-02 Implantable bioabsorbable article
DE1991621587 DE69121587T3 (en) 1990-12-06 1991-12-02 An implantable bioabsorbable article

Publications (1)

Publication Number Publication Date
WO1992010218A1 true true WO1992010218A1 (en) 1992-06-25

Family

ID=24495826

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1991/008972 WO1992010218A1 (en) 1990-12-06 1991-12-02 Implantable bioabsorbable article

Country Status (6)

Country Link
US (1) US6031148A (en)
JP (1) JPH06506366A (en)
CA (1) CA2094908C (en)
DE (2) DE69121587T3 (en)
EP (1) EP0560934B2 (en)
WO (1) WO1992010218A1 (en)

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017635A1 (en) * 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
EP0574091A2 (en) * 1992-06-11 1993-12-15 Innovations B.V. Dental Bioresorbable barrier element
EP0604022A1 (en) * 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
EP0609667A1 (en) * 1993-02-01 1994-08-10 Axel Dr. Kirsch Covering membrane
EP0610731A1 (en) * 1993-01-27 1994-08-17 United States Surgical Corporation Post-surgical anti-adhesion device
WO1994019029A1 (en) * 1993-02-18 1994-09-01 W.L. Gore & Associates, Inc. A laminated patch tissue repair sheet material
WO1995001138A1 (en) * 1993-07-02 1995-01-12 Materials Evolution And Development Usa, Inc. Implantable system for cell growth control
EP0636378A1 (en) * 1993-07-28 1995-02-01 JOHNSON & JOHNSON MEDICAL, INC. Absorbable composite materials for use in the treatment of periodontal disease
EP0637229A1 (en) * 1992-04-24 1995-02-08 Osteotech, Inc., Devices for preventing tissue adhesion
US5393594A (en) * 1993-10-06 1995-02-28 United States Surgical Corporation Absorbable non-woven fabric
EP0656196A1 (en) * 1993-12-02 1995-06-07 Meadox Medicals, Inc. Implantable tubular prosthesis
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5443458A (en) * 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
WO1995022305A1 (en) * 1994-02-18 1995-08-24 The University Court Of The University Of Glasgow Wound healing material
WO1995028900A1 (en) * 1994-04-27 1995-11-02 Axel Kirsch Covering system for defective points in bones and process for producing it
EP0708625A1 (en) * 1993-07-12 1996-05-01 The Regents Of The University Of California Soft tissue augmentation apparatus
EP0689807A3 (en) * 1994-06-27 1996-08-07 Advanced Cardiovascular System Biodegradable mesh-and-film stent
WO1996034634A1 (en) * 1995-05-01 1996-11-07 Sam Yang Co. Ltd. Implantable bioresorbable membrane and method for the preparation thereof
EP0744165A1 (en) * 1995-05-25 1996-11-27 Ellis Developments Limited Device for the repair of the rotator cuff of the shoulder
DE19520867A1 (en) * 1995-06-08 1996-12-12 Kirsch Axel covering membrane
WO1996041586A1 (en) * 1995-06-08 1996-12-27 Axel Kirsch Device for treating a bone recess
EP0773755A1 (en) * 1994-01-28 1997-05-21 JACOB-LABARRE, Jean T. Intraocular prostheses
DE19654884A1 (en) * 1996-03-04 1997-09-11 Kirsch Axel Membrane for tissue or bone regeneration
EP0809979A1 (en) * 1996-05-29 1997-12-03 MKE Metall- und Kunststoffwaren Erzeugungsgesellschaft m.b.H. Sheet or membrane for covering bone defect sites, process for manufacturing the sheet and nail for the position fixing of such a sheet
US5782907A (en) * 1995-07-13 1998-07-21 Devices For Vascular Intervention, Inc. Involuted spring stent and graft assembly and method of use
WO1999017817A1 (en) * 1997-10-02 1999-04-15 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
WO1999045860A1 (en) * 1998-03-11 1999-09-16 The University Court Of The University Of Glasgow Biocompatible substrate with a surface to which cells have a low tendency to attach
WO2000002494A1 (en) * 1998-07-10 2000-01-20 Eckhard Binder Moulded parts, especially films, for promoting the regeneration of bone material in the jaw
EP0782865A3 (en) * 1996-01-03 2000-02-02 Jürgens, Christian, Dr. med. Use of lactide polymers for prevention of adhesion
WO2000015152A1 (en) * 1998-09-14 2000-03-23 Bionx Implants Oy A bioabsorbable, layered composite material for guided bone tissue regeneration
US6120539A (en) * 1997-05-01 2000-09-19 C. R. Bard Inc. Prosthetic repair fabric
EP1038508A1 (en) * 1999-03-20 2000-09-27 Aesculap AG & Co. KG Prosthetic patch, method for its manufacture and its use in surgery
US6258124B1 (en) 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
WO2002022047A1 (en) * 2000-09-14 2002-03-21 C.R. Bard, Inc. Implantable prosthesis
ES2173796A1 (en) * 2000-06-20 2002-10-16 Caneiro Juan Manuel Bellon Wall prosthesis that stimulates and modulates the connective tissue, the tissue is integrated and enables mesothelial deposit, avoiding adhesions and visceral erosions.
US6497650B1 (en) 1999-07-28 2002-12-24 C. R. Bard, Inc. Hernia prosthesis
US6500777B1 (en) 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US6527801B1 (en) 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
US6652595B1 (en) 1996-03-25 2003-11-25 Davol Inc. Method of repairing inguinal hernias
WO2003099160A1 (en) * 2002-05-23 2003-12-04 Ethicon Gmbh Medical implant
EP1384450A1 (en) * 2002-07-21 2004-01-28 Aesculap Ag Flat implant for use in surgery
EP1405649A1 (en) * 2002-09-27 2004-04-07 Ethicon, Inc. Composite scaffolds seeded with mammalian cells
EP1466633A1 (en) * 2003-04-02 2004-10-13 Lifescan, Inc. Composite scaffolds seeded with mammalian cells
WO2004096086A1 (en) * 2003-04-28 2004-11-11 Gfe Medizintechnik Gmbh Surgical planar plug
WO2005112820A2 (en) * 2004-05-20 2005-12-01 Kensey Nash Corporation Anti-adhesion device
EP1609491A1 (en) * 2004-06-16 2005-12-28 Straumann Holding AG Barrier membrane
US7192604B2 (en) 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
US7282584B2 (en) 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
US7942104B2 (en) 2007-01-22 2011-05-17 Nuvasive, Inc. 3-dimensional embroidery structures via tension shaping
US7946236B2 (en) 2007-01-31 2011-05-24 Nuvasive, Inc. Using zigzags to create three-dimensional embroidered structures
US8048503B2 (en) 2005-07-29 2011-11-01 Gore Enterprise Holdings, Inc. Highly porous self-cohered web materials
US8048500B2 (en) 2005-07-29 2011-11-01 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
US8067071B2 (en) * 2005-07-29 2011-11-29 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
US8273010B2 (en) 2010-06-14 2012-09-25 Coloplast A/S Incontinence treatment device
US8377241B2 (en) 2005-07-29 2013-02-19 W. L. Gore & Associates, Inc. Method of making porous self-cohered web materials
US8574611B2 (en) 2007-07-12 2013-11-05 Straumann Holding Ag Composite bone repair material
US8597745B2 (en) 2005-07-29 2013-12-03 W. L. Gore & Associates, Inc. Composite self-cohered web materials
US8846070B2 (en) 2004-03-29 2014-09-30 Advanced Cardiovascular Systems, Inc. Biologically degradable compositions for medical applications
US8925177B2 (en) 2006-06-19 2015-01-06 Abbott Cardiovascular Systems Inc. Methods for improving stent retention on a balloon catheter
US9038260B2 (en) 2006-05-26 2015-05-26 Abbott Cardiovascular Systems Inc. Stent with radiopaque markers
US9072586B2 (en) 2008-10-03 2015-07-07 C.R. Bard, Inc. Implantable prosthesis
US9072820B2 (en) 2006-06-26 2015-07-07 Advanced Cardiovascular Systems, Inc. Polymer composite stent with polymer particles
US9173733B1 (en) 2006-08-21 2015-11-03 Abbott Cardiovascular Systems Inc. Tracheobronchial implantable medical device and methods of use
US9198785B2 (en) 2010-01-30 2015-12-01 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
WO2016011369A1 (en) * 2014-07-17 2016-01-21 Poriferous, LLC Orbital floor sheet
US9248034B2 (en) 2005-08-23 2016-02-02 Advanced Cardiovascular Systems, Inc. Controlled disintegrating implantable medical devices
WO2016019404A1 (en) * 2014-08-05 2016-02-11 Dietmar Sonnleitner Method for producing a multilayer film
US9283099B2 (en) 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US9295570B2 (en) 2001-09-19 2016-03-29 Abbott Laboratories Vascular Enterprises Limited Cold-molding process for loading a stent onto a stent delivery system
US9532888B2 (en) 2006-01-04 2017-01-03 Abbott Cardiovascular Systems Inc. Stents with radiopaque markers
US9827119B2 (en) 2010-01-30 2017-11-28 Abbott Cardiovascular Systems Inc. Polymer scaffolds having a low crossing profile

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831699C1 (en) * 1998-07-15 2000-04-27 Caremed Medical Produkte Ag implant holder
US6884427B1 (en) * 1999-02-08 2005-04-26 Aderans Research Institute, Inc. Filamentary means for introducing agents into tissue of a living host
US6638211B2 (en) * 2000-07-05 2003-10-28 Mentor Corporation Method for treating urinary incontinence in women and implantable device intended to correct urinary incontinence
FR2811218B1 (en) 2000-07-05 2003-02-28 Patrice Suslian An implantable device intended to correct urinary incontinence
CN1277585C (en) * 2000-08-08 2006-10-04 阿德兰斯研究院有限公司 Scaffolds for tissue engineered hair
US8167785B2 (en) 2000-10-12 2012-05-01 Coloplast A/S Urethral support system
US20060205995A1 (en) 2000-10-12 2006-09-14 Gyne Ideas Limited Apparatus and method for treating female urinary incontinence
GB0025068D0 (en) 2000-10-12 2000-11-29 Browning Healthcare Ltd Apparatus and method for treating female urinary incontinence
US6641525B2 (en) * 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
US7229453B2 (en) * 2001-01-23 2007-06-12 Ams Research Corporation Pelvic floor implant system and method of assembly
US6612977B2 (en) 2001-01-23 2003-09-02 American Medical Systems Inc. Sling delivery system and method of use
US20020147382A1 (en) * 2001-01-23 2002-10-10 Neisz Johann J. Surgical articles and methods
US6652450B2 (en) 2001-01-23 2003-11-25 American Medical Systems, Inc. Implantable article and method for treating urinary incontinence using means for repositioning the implantable article
US7407480B2 (en) 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US20040068284A1 (en) * 2002-01-29 2004-04-08 Barrows Thomas H. Method for stimulating hair growth and kit for carrying out said method
US6783554B2 (en) 2001-02-20 2004-08-31 Atrium Medical Corporation Pile mesh prosthesis
US6652585B2 (en) 2001-02-28 2003-11-25 Sdgi Holdings, Inc. Flexible spine stabilization system
US6827743B2 (en) * 2001-02-28 2004-12-07 Sdgi Holdings, Inc. Woven orthopedic implants
US7229441B2 (en) * 2001-02-28 2007-06-12 Warsaw Orthopedic, Inc. Flexible systems for spinal stabilization and fixation
US7344539B2 (en) * 2001-03-30 2008-03-18 Depuy Acromed, Inc. Intervertebral connection system
US20030004568A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Coated combination vaso-occlusive device
EP1392175A2 (en) * 2001-05-04 2004-03-03 Concentric Medical Hydrogel filament vaso-occlusive device
US20020193812A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel vaso-occlusive device
EP1387670B1 (en) * 2001-05-11 2008-10-15 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Immune modulation device for use in animals
US6790455B2 (en) 2001-09-14 2004-09-14 The Research Foundation At State University Of New York Cell delivery system comprising a fibrous matrix and cells
US6648921B2 (en) * 2001-10-03 2003-11-18 Ams Research Corporation Implantable article
US6800082B2 (en) 2001-10-19 2004-10-05 Ethicon, Inc. Absorbable mesh device
US20030093111A1 (en) * 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
US6790213B2 (en) 2002-01-07 2004-09-14 C.R. Bard, Inc. Implantable prosthesis
US7357773B2 (en) 2002-03-07 2008-04-15 Ams Research Corporation Handle and surgical article
US6911003B2 (en) 2002-03-07 2005-06-28 Ams Research Corporation Transobturator surgical articles and methods
US7070556B2 (en) * 2002-03-07 2006-07-04 Ams Research Corporation Transobturator surgical articles and methods
US20030212456A1 (en) * 2002-05-09 2003-11-13 John Lipchitz Implant for tissue repair
US8187326B2 (en) * 2002-05-22 2012-05-29 Advanced Technologies And Regenerative Medicine, Llc. Attachment of absorbable tissue scaffolds to fixation devices
US6989034B2 (en) 2002-05-31 2006-01-24 Ethicon, Inc. Attachment of absorbable tissue scaffolds to fixation devices
EP1536746B1 (en) * 2002-06-24 2013-05-08 Incept, LLC Fillers and methods for displacing tissues to improve radiological outcomes
US20040019360A1 (en) * 2002-07-25 2004-01-29 Farnsworth Ted R. Tissue repair device with a removable support member
US8097007B2 (en) 2002-08-02 2012-01-17 C. R. Bard, Inc. Self-anchoring sling and introducer system
US7682392B2 (en) * 2002-10-30 2010-03-23 Depuy Spine, Inc. Regenerative implants for stabilizing the spine and devices for attachment of said implants
US6808486B1 (en) 2002-12-03 2004-10-26 Pat O'Donnell Surgical instrument for treating female urinary stress incontinence
US7771345B1 (en) 2002-12-03 2010-08-10 O'donnell Pat D Surgical instrument for treating female urinary stress incontinence
US20040115164A1 (en) * 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
US7976452B2 (en) * 2003-06-11 2011-07-12 L.Vad Technology, Inc. Long term ambulatory intro-aortic balloon pump with percutaneous access device
GB0307082D0 (en) 2003-03-27 2003-04-30 Gyne Ideas Ltd Drug delivery device and method
EP1610714A2 (en) 2003-03-28 2006-01-04 Analytic Biosurgical Solutions - ABISS Implant for treatment of a rectocele and device for placement of said implant
US7494495B2 (en) 2003-03-28 2009-02-24 Coloplast A/S Method and implant for curing cystocele
US7846201B2 (en) * 2004-02-20 2010-12-07 The Children's Hospital Of Philadelphia Magnetically-driven biodegradable gene delivery nanoparticles formulated with surface-attached polycationic complex
US8298292B2 (en) * 2003-04-16 2012-10-30 Howmedica Osteonics Corp. Craniofacial implant
US7655047B2 (en) * 2003-04-16 2010-02-02 Porex Surgical, Inc. Craniofacial implant
US9028829B2 (en) * 2004-02-20 2015-05-12 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US8562505B2 (en) 2004-02-20 2013-10-22 The Children's Hospital Of Philadelphia Uniform field magnetization and targeting of therapeutic formulations
US7497864B2 (en) * 2003-04-30 2009-03-03 Marctec, Llc. Tissue fastener and methods for using same
CN1798533A (en) * 2003-04-30 2006-07-05 Ams研究公司 Prosthesis for the treatment of urogenital prolapse and female urinary incontinence
EP1644478A4 (en) * 2003-06-30 2008-07-23 Lifescan Inc Multi-staged absorbable nonwoven structures for culturing pancreatic cells
US7931695B2 (en) * 2003-07-15 2011-04-26 Kensey Nash Corporation Compliant osteosynthesis fixation plate
US7347812B2 (en) * 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
US20050202067A1 (en) * 2003-10-28 2005-09-15 Gkss Forschungszentrum Matrix structure and hybrid matrix system for inducing a neofacia, their use and method for generating a neofacia
US20050113849A1 (en) * 2003-11-26 2005-05-26 Nicholas Popadiuk Prosthetic repair device
US7597885B2 (en) * 2004-03-26 2009-10-06 Aderans Research Institute, Inc. Tissue engineered biomimetic hair follicle graft
JP4977600B2 (en) * 2004-04-20 2012-07-18 ジェンザイム・コーポレーション Mesh implants for surgery
US7500945B2 (en) * 2004-04-30 2009-03-10 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
US7811222B2 (en) * 2004-04-30 2010-10-12 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
US7351197B2 (en) * 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
GB0411360D0 (en) 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
US20050278037A1 (en) * 2004-06-11 2005-12-15 Analytic Biosurgical Solutions-Abiss Implant for the treatment of cystocele and rectocele
JP2008509679A (en) * 2004-08-13 2008-04-03 アデランス リサーチ インスティテュート インコーポレイテッド Organogenesis from isolated cells
US20060173468A1 (en) * 2005-01-28 2006-08-03 Marc Simmon Obturator introducer with snare
US8414907B2 (en) 2005-04-28 2013-04-09 Warsaw Orthopedic, Inc. Coatings on medical implants to guide soft tissue healing
US9119901B2 (en) * 2005-04-28 2015-09-01 Warsaw Orthopedic, Inc. Surface treatments for promoting selective tissue attachment to medical impants
US9179996B2 (en) * 2005-04-29 2015-11-10 Dtherapeutics, Llc Tissue engineering of blood vessels
CA2615130A1 (en) 2005-07-26 2007-02-08 Ams Research Corporation Methods and systems for treatment of prolapse
US7704225B2 (en) 2005-07-29 2010-04-27 L-Vad Technology, Inc. Percutaneous access device system facilitating cell growth thereon
US8128552B2 (en) * 2005-08-22 2012-03-06 O'donnell Pat D Surgical instrument for treating female pelvic prolapse
US20080207989A1 (en) * 2005-08-29 2008-08-28 Ams Research Corporation System For Positioning Support Mesh in a Patient
ES2470338T3 (en) 2005-11-14 2014-06-23 C.R. Bard, Inc. Anchor System sling
WO2007062386A3 (en) * 2005-11-22 2007-11-01 Aderans Res Inst Inc Hair follicle graft from tissue engineered skin
US20070122387A1 (en) * 2005-11-22 2007-05-31 Aderans Research Institute, Inc. Hair grafts derived from plucked hair
US20070128243A1 (en) 2005-12-02 2007-06-07 Xylos Corporation Implantable microbial cellulose materials for various medical applications
US7709631B2 (en) 2006-03-13 2010-05-04 Xylos Corporation Oxidized microbial cellulose and use thereof
FR2898502B1 (en) * 2006-03-16 2012-06-15 Sofradim Production Fabric three-dimensional prosthetic has resorbable dense face
JP2007289634A (en) * 2006-03-30 2007-11-08 Gc Corp Bioabsorbable tube and its manufacturing method
US9084664B2 (en) 2006-05-19 2015-07-21 Ams Research Corporation Method and articles for treatment of stress urinary incontinence
US7872068B2 (en) * 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
US20070286884A1 (en) * 2006-06-13 2007-12-13 Xylos Corporation Implantable microbial cellulose materials for hard tissue repair and regeneration
KR101115493B1 (en) * 2006-06-16 2012-03-13 에이엠에스 리써치 코오포레이션 Surgical implants, tools, and methods for treating pelvic conditions
US7824383B2 (en) * 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
US20090259092A1 (en) * 2006-06-22 2009-10-15 Ogdahl Jason W Adjustable Sling and Method of Treating Pelvic Conditions
CA2654294C (en) * 2006-06-22 2016-09-20 Ams Research Corporation Adjustable tension incontinence sling assemblies
US7833284B2 (en) 2006-06-28 2010-11-16 The Cleveland Clinic Foundation Anti-adhesion membrane
US8529597B2 (en) * 2006-08-09 2013-09-10 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US9138208B2 (en) 2006-08-09 2015-09-22 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US8864809B2 (en) * 2006-08-09 2014-10-21 Coherex Medical, Inc. Systems and devices for reducing the size of an internal tissue opening
US8480559B2 (en) 2006-09-13 2013-07-09 C. R. Bard, Inc. Urethral support system
US8652154B2 (en) * 2006-12-28 2014-02-18 Orthovita, Inc. Non-resorbable implantable guides
EP2111187A4 (en) * 2007-02-14 2014-10-01 Synthasome Inc Synthethic structure for soft tissue repair
US7985537B2 (en) * 2007-06-12 2011-07-26 Aderans Research Institute, Inc. Methods for determining the hair follicle inductive properties of a composition
US20110038911A1 (en) * 2007-08-09 2011-02-17 Gunze Limited Prosthetic material for living organ
US8206280B2 (en) 2007-11-13 2012-06-26 C. R. Bard, Inc. Adjustable tissue support member
EP2070557A1 (en) 2007-12-12 2009-06-17 Xylos Corporation Implantable microbial cellulose materials for hard tissue repair and regeneration
US8206632B2 (en) * 2007-12-18 2012-06-26 Ethicon, Inc. Methods of making composite prosthetic devices having improved bond strength
JP5702515B2 (en) * 2007-12-28 2015-04-15 東洋紡株式会社 Nerve regeneration-inducing tube
WO2009121001A1 (en) * 2008-03-28 2009-10-01 Coherex Medical, Inc. Delivery systems for a medical device and related methods
US8727963B2 (en) * 2008-07-31 2014-05-20 Ams Research Corporation Methods and implants for treating urinary incontinence
US9017243B2 (en) 2008-08-25 2015-04-28 Ams Research Corporation Minimally invasive implant and method
US20100172889A1 (en) * 2008-12-05 2010-07-08 Catchmark Jeffrey M Degradable biomolecule compositions
WO2010099333A3 (en) * 2009-02-25 2011-05-26 Howmedica Osteonics Corp. Bone graft material containment structures
US8696759B2 (en) 2009-04-15 2014-04-15 DePuy Synthes Products, LLC Methods and devices for implants with calcium phosphate
US20100268227A1 (en) * 2009-04-15 2010-10-21 Depuy Products, Inc. Methods and Devices for Bone Attachment
WO2010128039A1 (en) * 2009-05-07 2010-11-11 Dsm Ip Assets B.V. Biodegradable composite comprising a biodegradable polymer and a glass fiber
US20110086236A1 (en) * 2009-10-13 2011-04-14 The Penn State Research Foundation Composites containing polypeptides attached to polysaccharides and molecules
US9060837B2 (en) * 2009-11-23 2015-06-23 Ams Research Corporation Patterned sling implant and method
KR101694742B1 (en) * 2009-11-23 2017-01-11 에이엠에스 리서치 코포레이션 Patterned implant and method
JP5820815B2 (en) 2009-12-15 2015-11-24 インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc Implants and biodegradable reference marker
DE102009060377B4 (en) * 2009-12-24 2016-10-20 Richard Wolf Gmbh trocar
US8475536B2 (en) * 2010-01-29 2013-07-02 DePuy Synthes Products, LLC Methods and devices for implants with improved cement adhesion
US9526600B2 (en) 2010-07-20 2016-12-27 Warsaw Orthopedic, Inc. Biodegradable stents and methods for treating periodontal disease
US9468512B2 (en) 2010-10-06 2016-10-18 Astora Women's Health, Llc Implants with absorbable and non-absorbable features for the treatment of female pelvic conditions
US9572648B2 (en) 2010-12-21 2017-02-21 Justin M. Crank Implantable slings and anchor systems
US9750590B2 (en) 2011-03-28 2017-09-05 Andrew P. VanDeWeghe Implants, tools, and methods for treatment of pelvic conditions
US8808162B2 (en) 2011-03-28 2014-08-19 Ams Research Corporation Implants, tools, and methods for treatment of pelvic conditions
US8579990B2 (en) * 2011-03-30 2013-11-12 Ethicon, Inc. Tissue repair devices of rapid therapeutic absorbency
US9492259B2 (en) 2011-03-30 2016-11-15 Astora Women's Health, Llc Expandable implant system
US9351723B2 (en) 2011-06-30 2016-05-31 Astora Women's Health, Llc Implants, tools, and methods for treatments of pelvic conditions
US9414903B2 (en) 2011-07-22 2016-08-16 Astora Women's Health, Llc Pelvic implant system and method
US8998059B2 (en) 2011-08-01 2015-04-07 Ethicon Endo-Surgery, Inc. Adjunct therapy device having driver with cavity for hemostatic agent
US9492191B2 (en) 2011-08-04 2016-11-15 Astora Women's Health, Llc Tools and methods for treatment of pelvic conditions
US9492170B2 (en) 2011-08-10 2016-11-15 Ethicon Endo-Surgery, Inc. Device for applying adjunct in endoscopic procedure
US9101359B2 (en) 2011-09-13 2015-08-11 Ethicon Endo-Surgery, Inc. Surgical staple cartridge with self-dispensing staple buttress
US8998060B2 (en) 2011-09-13 2015-04-07 Ethicon Endo-Surgery, Inc. Resistive heated surgical staple cartridge with phase change sealant
US8814025B2 (en) 2011-09-15 2014-08-26 Ethicon Endo-Surgery, Inc. Fibrin pad matrix with suspended heat activated beads of adhesive
US9125649B2 (en) 2011-09-15 2015-09-08 Ethicon Endo-Surgery, Inc. Surgical instrument with filled staple
US9254180B2 (en) 2011-09-15 2016-02-09 Ethicon Endo-Surgery, Inc. Surgical instrument with staple reinforcement clip
US9393018B2 (en) 2011-09-22 2016-07-19 Ethicon Endo-Surgery, Inc. Surgical staple assembly with hemostatic feature
US9198644B2 (en) 2011-09-22 2015-12-01 Ethicon Endo-Surgery, Inc. Anvil cartridge for surgical fastening device
US8985429B2 (en) 2011-09-23 2015-03-24 Ethicon Endo-Surgery, Inc. Surgical stapling device with adjunct material application feature
US8899464B2 (en) 2011-10-03 2014-12-02 Ethicon Endo-Surgery, Inc. Attachment of surgical staple buttress to cartridge
US9089326B2 (en) 2011-10-07 2015-07-28 Ethicon Endo-Surgery, Inc. Dual staple cartridge for surgical stapler
JP6199883B2 (en) 2011-12-05 2017-09-20 インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc Medical organogel processes and compositions
EP2812042A1 (en) * 2012-02-08 2014-12-17 Boston Scientific Scimed, Inc. Porous surgical films
WO2013119458A1 (en) * 2012-02-10 2013-08-15 DePuy Synthes Products, LLC Porous implant materials and related methods
US9107979B2 (en) 2012-12-06 2015-08-18 Industrial Technology Research Institute Bioresorbable porous film
US20140205971A1 (en) * 2013-01-18 2014-07-24 The Trustees Of The Stevens Institute Of Technology Modification of root form dental implants for accelerated tissue regeneration
WO2014179720A1 (en) 2013-05-02 2014-11-06 University Of South Florida Implantable sonic windows
WO2015172212A1 (en) * 2014-05-15 2015-11-19 Aguedo Aragones Reabsorbable hybrid device for guided tissue regeneration

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274898A2 (en) * 1986-12-27 1988-07-20 Ethicon Inc. Implant
WO1988005312A1 (en) * 1987-01-13 1988-07-28 Materials Consultants Oy New surgical materials and devices
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
WO1990000410A1 (en) * 1988-07-05 1990-01-25 Biocon Oy Reinforced polymeric biomaterial films
FR2635966A1 (en) * 1988-09-08 1990-03-09 Ethicon Inc tubular surgical implant and resorbable and process for its manufacturing
WO1990013302A1 (en) * 1989-04-28 1990-11-15 Brigham And Women's Hospital Novel materials and methods for guided tissue regeneration

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR560934A (en) * 1923-01-12 1923-10-12 Method and apparatus for advanced destruction by distillation of household waste and other substances and recovery of useful materials contained therein
US2748781A (en) * 1953-08-24 1956-06-05 Collat Edgar Means for dental hygiene
US2991224A (en) * 1958-08-18 1961-07-04 Dale V Bell Gingival pack
US3386440A (en) * 1965-10-19 1968-06-04 Milton J. Cohen Dental pad
FR1499912A (en) * 1966-03-10 1967-11-03 root protection Plateau
US3589011A (en) * 1969-07-10 1971-06-29 Meer Sneer Endosseous pin dental implant method and dental devices used therein
CA962021A (en) * 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
CA962806A (en) * 1970-06-04 1975-02-18 Ontario Research Foundation Surgical prosthetic device
US3754332A (en) * 1970-09-09 1973-08-28 L Warren Treatment member
CA1016457A (en) * 1971-05-20 1977-08-30 Charles A. Homsy Implantable material and appliance, method of preparing same and method of stabilizing implants
FR2155073A5 (en) * 1971-10-06 1973-05-18 Rhone Poulenc Sa
US3879767A (en) * 1972-01-26 1975-04-29 Cutter Lab Prosthesis for articulating body structures
US3909852A (en) * 1973-12-17 1975-10-07 Charles A Homsy Implantable substitute structure for at least part of the middle ear bony chain
US4039653A (en) * 1974-01-23 1977-08-02 Defoney, Brenman, Mayes & Baron Long-acting articles for oral delivery and process
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US3971670A (en) * 1974-07-17 1976-07-27 Homsy Charles A Implantable structure and method of making same
FR2278317B1 (en) * 1974-07-19 1977-10-21 Commissariat Energie Atomique
US3971134A (en) * 1975-01-31 1976-07-27 General Atomic Company Carbon dental implant with artificial periodontal ligament
US4007494A (en) * 1975-04-11 1977-02-15 Glasrock Products, Inc. Bone cap
US4164794A (en) * 1977-04-14 1979-08-21 Union Carbide Corporation Prosthetic devices having coatings of selected porous bioengineering thermoplastics
US4175326A (en) * 1977-10-26 1979-11-27 Forsyth Dental Infirmary For Children Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases
US4244689A (en) * 1978-06-27 1981-01-13 Arthur Ashman Endosseous plastic implant
US4303712A (en) * 1979-01-22 1981-12-01 Woodroof E Aubrey Fabric silicone elastomer composite
US4195405A (en) * 1979-03-15 1980-04-01 Paris Glove Of Canada Ltd. Combined mitten and glove
US4252525A (en) * 1979-12-17 1981-02-24 Child Frank W Dental implant
US4321914A (en) * 1980-04-22 1982-03-30 W. L. Gore & Associates, Inc. Percutaneous conduit having PTFE skirt
US4400833A (en) * 1981-06-10 1983-08-30 Kurland Kenneth Z Means and method of implanting bioprosthetics
US4535485A (en) * 1982-03-12 1985-08-20 Medical Biological Sciences, Inc. Polymeric acrylic prothesis
US4520821A (en) * 1982-04-30 1985-06-04 The Regents Of The University Of California Growing of long-term biological tissue correction structures in vivo
US4492577A (en) * 1982-10-25 1985-01-08 Farris Edward T Surgical implants with solid interiors and porous surfaces
US4534349A (en) * 1983-02-02 1985-08-13 Minnesota Mining And Manufacturing Company Absorbable sutureless nerve repair device
US4883618A (en) * 1983-02-02 1989-11-28 Minnesota Mining And Manufacturing Company Absorbable nerve repair device and method
US4886870A (en) * 1984-05-21 1989-12-12 Massachusetts Institute Of Technology Bioerodible articles useful as implants and prostheses having predictable degradation rates
JPS59202401A (en) * 1983-05-02 1984-11-16 Nippon Telegr & Teleph Corp <Ntt> Optical fiber and its manufacture
US4643734A (en) * 1983-05-05 1987-02-17 Hexcel Corporation Lactide/caprolactone polymer, method of making the same, composites thereof, and prostheses produced therefrom
US4531916A (en) * 1983-07-08 1985-07-30 W. L. Gore & Associates, Inc. Dental implant with expanded PTFE gingival interface
US4655777A (en) * 1983-12-19 1987-04-07 Southern Research Institute Method of producing biodegradable prosthesis and products therefrom
US4837285A (en) * 1984-03-27 1989-06-06 Medimatrix Collagen matrix beads for soft tissue repair
JPS61122855A (en) * 1984-07-06 1986-06-10 Gore & Ass Product for treating tooth disease
WO1990011730A1 (en) * 1989-04-05 1990-10-18 W.L. Gore & Associates, Inc. Methods and articles for treating periodontal disease and bone defects
US5032445A (en) * 1984-07-06 1991-07-16 W. L. Gore & Associates Methods and articles for treating periodontal disease and bone defects
WO1986002824A1 (en) * 1984-11-07 1986-05-22 Dan Lundgren Element for controlled growth into surgically intervened areas
US4595713A (en) * 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
US4923470A (en) * 1985-04-25 1990-05-08 American Cyanamid Company Prosthetic tubular article made with four chemically distinct fibers
US5061281A (en) * 1985-12-17 1991-10-29 Allied-Signal Inc. Bioresorbable polymers and implantation devices thereof
US4743252A (en) * 1986-01-13 1988-05-10 Corvita Corporation Composite grafts
US5002572A (en) * 1986-09-11 1991-03-26 Picha George J Biological implant with textured surface
FI80605C (en) * 1986-11-03 1990-07-10 Biocon Oy Benkirurgisk biokompositmaterial.
JP2637782B2 (en) * 1987-08-12 1997-08-06 エチコン・インコーポレーテツド Resorbable surgical networks and prostheses made therefrom
US4916193A (en) * 1987-12-17 1990-04-10 Allied-Signal Inc. Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US4961707A (en) * 1987-12-22 1990-10-09 University Of Florida Guided periodontal tissue regeneration
US4864176A (en) * 1988-07-29 1989-09-05 Rem Technologies, Inc. Stator support structure with stamped end plates
EP0408673A4 (en) * 1988-08-22 1992-03-11 The Commonwealth Scientific And Industrial Research Organisation Acid treated polyacrylic acid grafted fluorocarbon polymer surface for cell attachment
GB2222954B (en) * 1988-08-31 1991-11-13 Ethicon Inc Tubular implant and process for the production thereof
CA1323959C (en) * 1988-09-16 1993-11-09 Recum Andreas F. Von Soft tissue implant with micron-scale surface texture to optimize anchorage
US5024671A (en) * 1988-09-19 1991-06-18 Baxter International Inc. Microporous vascular graft
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
JPH0683713B2 (en) * 1988-12-23 1994-10-26 グイドール・アクチボラグ Surgical barrier
US5077049A (en) * 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
DE69120177T2 (en) * 1990-09-10 1996-10-10 Synthes Ag Membrane for bone regeneration
WO1994013596A1 (en) * 1992-12-04 1994-06-23 Cementa Ab Method of grinding cement

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0274898A2 (en) * 1986-12-27 1988-07-20 Ethicon Inc. Implant
WO1988005312A1 (en) * 1987-01-13 1988-07-28 Materials Consultants Oy New surgical materials and devices
US4870966A (en) * 1988-02-01 1989-10-03 American Cyanamid Company Bioabsorbable surgical device for treating nerve defects
WO1990000410A1 (en) * 1988-07-05 1990-01-25 Biocon Oy Reinforced polymeric biomaterial films
FR2635966A1 (en) * 1988-09-08 1990-03-09 Ethicon Inc tubular surgical implant and resorbable and process for its manufacturing
WO1990013302A1 (en) * 1989-04-28 1990-11-15 Brigham And Women's Hospital Novel materials and methods for guided tissue regeneration

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Periodontology, vol. 59, no. 1, January 1988, I. MAGNUSSON et al.: "New attachment formation following controlled tissue regeneration using biodegradable membranes", pages 1-6 (cited in the application) *

Cited By (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017635A1 (en) * 1992-03-04 1993-09-16 C.R. Bard, Inc. Composite prosthesis and method for limiting the incidence of postoperative adhesions
EP0637229A1 (en) * 1992-04-24 1995-02-08 Osteotech, Inc., Devices for preventing tissue adhesion
EP0637229A4 (en) * 1992-04-24 1998-11-25 Osteotech Inc Devices for preventing tissue adhesion.
EP0574091A3 (en) * 1992-06-11 1994-03-23 Dental Innovations B V
EP0574091A2 (en) * 1992-06-11 1993-12-15 Innovations B.V. Dental Bioresorbable barrier element
US5443458A (en) * 1992-12-22 1995-08-22 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method of manufacture
EP0604022A1 (en) * 1992-12-22 1994-06-29 Advanced Cardiovascular Systems, Inc. Multilayered biodegradable stent and method for its manufacture
EP0610731A1 (en) * 1993-01-27 1994-08-17 United States Surgical Corporation Post-surgical anti-adhesion device
US5795584A (en) * 1993-01-27 1998-08-18 United States Surgical Corporation Post-surgical anti-adhesion device
EP0609667A1 (en) * 1993-02-01 1994-08-10 Axel Dr. Kirsch Covering membrane
US5433996A (en) * 1993-02-18 1995-07-18 W. L. Gore & Associates, Inc. Laminated patch tissue repair sheet material
WO1994019029A1 (en) * 1993-02-18 1994-09-01 W.L. Gore & Associates, Inc. A laminated patch tissue repair sheet material
US5614284A (en) * 1993-02-18 1997-03-25 W. L. Gore & Associates, Inc. Laminated patch tissue repair sheet material
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5618299A (en) * 1993-04-23 1997-04-08 Advanced Cardiovascular Systems, Inc. Ratcheting stent
WO1995001138A1 (en) * 1993-07-02 1995-01-12 Materials Evolution And Development Usa, Inc. Implantable system for cell growth control
US5941910A (en) * 1993-07-12 1999-08-24 The Regents Of The University Of California Soft tissue augmentation apparatus
US5782913A (en) * 1993-07-12 1998-07-21 The Regents Of The University Of California Soft tissue augmentation apparatus
EP0708625A4 (en) * 1993-07-12 1997-04-02 Univ California Soft tissue augmentation apparatus
EP0708625A1 (en) * 1993-07-12 1996-05-01 The Regents Of The University Of California Soft tissue augmentation apparatus
EP0636378A1 (en) * 1993-07-28 1995-02-01 JOHNSON &amp; JOHNSON MEDICAL, INC. Absorbable composite materials for use in the treatment of periodontal disease
US5447940A (en) * 1993-07-28 1995-09-05 Johnson & Johnson Medical, Inc. Absorbable composite materials for use in the treatment of periodontal disease
US5393594A (en) * 1993-10-06 1995-02-28 United States Surgical Corporation Absorbable non-woven fabric
EP0656196A1 (en) * 1993-12-02 1995-06-07 Meadox Medicals, Inc. Implantable tubular prosthesis
US5800510A (en) * 1993-12-02 1998-09-01 Meadox Medicals, Inc. Implantable tubular prosthesis
US5911753A (en) * 1993-12-02 1999-06-15 Meadox Medicals, Inc. Implantable tubular prosthesis
US6814753B2 (en) 1993-12-02 2004-11-09 Scimed Life Systems, Inc. Implantable tubular prosthesis
US5527353A (en) * 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
US6589468B1 (en) 1993-12-02 2003-07-08 Meadox Medical, Inc. Method of forming an implantable tubular prosthesis
US6099557A (en) * 1993-12-02 2000-08-08 Meadox Medicals, Inc. Implantable tubular prosthesis
EP0773755A1 (en) * 1994-01-28 1997-05-21 JACOB-LABARRE, Jean T. Intraocular prostheses
EP0773755A4 (en) * 1994-01-28 1997-10-08 Jacob Labarre Jean T Intraocular prostheses
US5833641A (en) * 1994-02-18 1998-11-10 The University Court Of The University Of Glasgow Wound healing material
WO1995022305A1 (en) * 1994-02-18 1995-08-24 The University Court Of The University Of Glasgow Wound healing material
US5824088A (en) * 1994-04-27 1998-10-20 Kirsch; Axel Cover device for bone voids and method for the manufacture thereof
WO1995028900A1 (en) * 1994-04-27 1995-11-02 Axel Kirsch Covering system for defective points in bones and process for producing it
US5629077A (en) * 1994-06-27 1997-05-13 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
EP0689807A3 (en) * 1994-06-27 1996-08-07 Advanced Cardiovascular System Biodegradable mesh-and-film stent
US5766710A (en) * 1994-06-27 1998-06-16 Advanced Cardiovascular Systems, Inc. Biodegradable mesh and film stent
WO1996034634A1 (en) * 1995-05-01 1996-11-07 Sam Yang Co. Ltd. Implantable bioresorbable membrane and method for the preparation thereof
EP0744165A1 (en) * 1995-05-25 1996-11-27 Ellis Developments Limited Device for the repair of the rotator cuff of the shoulder
WO1996041586A1 (en) * 1995-06-08 1996-12-27 Axel Kirsch Device for treating a bone recess
DE19520867C2 (en) * 1995-06-08 1998-05-20 Kirsch Axel covering membrane
DE19520867A1 (en) * 1995-06-08 1996-12-12 Kirsch Axel covering membrane
US5782907A (en) * 1995-07-13 1998-07-21 Devices For Vascular Intervention, Inc. Involuted spring stent and graft assembly and method of use
EP0782865A3 (en) * 1996-01-03 2000-02-02 Jürgens, Christian, Dr. med. Use of lactide polymers for prevention of adhesion
DE19654884A1 (en) * 1996-03-04 1997-09-11 Kirsch Axel Membrane for tissue or bone regeneration
WO1997032616A1 (en) * 1996-03-04 1997-09-12 Axel Kirsch Covering membrane, moulded bodies produced therefrom and process for the production thereof
DE19654884C2 (en) * 1996-03-04 1999-07-29 Kirsch Axel moldings
US6652595B1 (en) 1996-03-25 2003-11-25 Davol Inc. Method of repairing inguinal hernias
EP0809979A1 (en) * 1996-05-29 1997-12-03 MKE Metall- und Kunststoffwaren Erzeugungsgesellschaft m.b.H. Sheet or membrane for covering bone defect sites, process for manufacturing the sheet and nail for the position fixing of such a sheet
US6500777B1 (en) 1996-06-28 2002-12-31 Ethicon, Inc. Bioresorbable oxidized cellulose composite material for prevention of postsurgical adhesions
US6120539A (en) * 1997-05-01 2000-09-19 C. R. Bard Inc. Prosthetic repair fabric
US6270530B1 (en) 1997-05-01 2001-08-07 C.R. Bard, Inc. Prosthetic repair fabric
US6165217A (en) * 1997-10-02 2000-12-26 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
WO1999017817A1 (en) * 1997-10-02 1999-04-15 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
US6309423B2 (en) 1997-10-02 2001-10-30 Gore Enterprise Holdings, Inc. Self-cohering, continuous filament non-woven webs
WO1999045860A1 (en) * 1998-03-11 1999-09-16 The University Court Of The University Of Glasgow Biocompatible substrate with a surface to which cells have a low tendency to attach
US6720469B1 (en) 1998-03-11 2004-04-13 The University Court Of The University Of Glasgow Cell adhesion
WO2000002494A1 (en) * 1998-07-10 2000-01-20 Eckhard Binder Moulded parts, especially films, for promoting the regeneration of bone material in the jaw
WO2000015152A1 (en) * 1998-09-14 2000-03-23 Bionx Implants Oy A bioabsorbable, layered composite material for guided bone tissue regeneration
US6350284B1 (en) 1998-09-14 2002-02-26 Bionx Implants, Oy Bioabsorbable, layered composite material for guided bone tissue regeneration
EP1038508A1 (en) * 1999-03-20 2000-09-27 Aesculap AG &amp; Co. KG Prosthetic patch, method for its manufacture and its use in surgery
EP1570806A3 (en) * 1999-03-20 2006-09-27 Aesculap AG &amp; Co. KG Prosthetic patch, method for its manufacture and its use in surgery
US6447551B1 (en) 1999-03-20 2002-09-10 Aesculap Ag & Co. Kg Flat implant, process for its production and use in surgery
US6258124B1 (en) 1999-05-10 2001-07-10 C. R. Bard, Inc. Prosthetic repair fabric
US6497650B1 (en) 1999-07-28 2002-12-24 C. R. Bard, Inc. Hernia prosthesis
US6527801B1 (en) 2000-04-13 2003-03-04 Advanced Cardiovascular Systems, Inc. Biodegradable drug delivery material for stent
ES2173796A1 (en) * 2000-06-20 2002-10-16 Caneiro Juan Manuel Bellon Wall prosthesis that stimulates and modulates the connective tissue, the tissue is integrated and enables mesothelial deposit, avoiding adhesions and visceral erosions.
EP1847233A2 (en) 2000-09-14 2007-10-24 C.R.Bard, Inc. Implantable Prosthesis
US8182545B2 (en) 2000-09-14 2012-05-22 C.R. Bard, Inc. Implantable prosthesis
WO2002022047A1 (en) * 2000-09-14 2002-03-21 C.R. Bard, Inc. Implantable prosthesis
EP1847233A3 (en) * 2000-09-14 2007-10-31 C.R.Bard, Inc. Implantable Prosthesis
US7192604B2 (en) 2000-12-22 2007-03-20 Ethicon, Inc. Implantable biodegradable devices for musculoskeletal repair or regeneration
US9295570B2 (en) 2001-09-19 2016-03-29 Abbott Laboratories Vascular Enterprises Limited Cold-molding process for loading a stent onto a stent delivery system
WO2003099160A1 (en) * 2002-05-23 2003-12-04 Ethicon Gmbh Medical implant
EP1384450A1 (en) * 2002-07-21 2004-01-28 Aesculap Ag Flat implant for use in surgery
EP1405649A1 (en) * 2002-09-27 2004-04-07 Ethicon, Inc. Composite scaffolds seeded with mammalian cells
EP1466633A1 (en) * 2003-04-02 2004-10-13 Lifescan, Inc. Composite scaffolds seeded with mammalian cells
CN100563600C (en) 2003-04-02 2009-12-02 生命扫描有限公司 Composite scaffolds seeded with mammalian cells
WO2004096086A1 (en) * 2003-04-28 2004-11-11 Gfe Medizintechnik Gmbh Surgical planar plug
US8846070B2 (en) 2004-03-29 2014-09-30 Advanced Cardiovascular Systems, Inc. Biologically degradable compositions for medical applications
US8361164B2 (en) 2004-05-20 2013-01-29 Kensey Nash Corporation Anti-adhesion device
WO2005112820A2 (en) * 2004-05-20 2005-12-01 Kensey Nash Corporation Anti-adhesion device
WO2005112820A3 (en) * 2004-05-20 2006-06-15 Kensey Nash Corp Anti-adhesion device
US7282584B2 (en) 2004-06-16 2007-10-16 Straumann Holding Ag Methylene blue
US7741427B2 (en) 2004-06-16 2010-06-22 Straumann Holding Ag Barrier membrane
EP1609491A1 (en) * 2004-06-16 2005-12-28 Straumann Holding AG Barrier membrane
US8044172B2 (en) 2004-06-16 2011-10-25 Straumann Holding Ag Barrier membrane
WO2005123156A1 (en) * 2004-06-16 2005-12-29 Straumann Holding Ag Barrier membrane
US8227460B2 (en) 2004-06-16 2012-07-24 Straumann Holding Ag Methylene blue
KR100899725B1 (en) * 2004-06-16 2009-05-27 스트라우만 홀딩 에이쥐 Barrier Membrane
US9283099B2 (en) 2004-08-25 2016-03-15 Advanced Cardiovascular Systems, Inc. Stent-catheter assembly with a releasable connection for stent retention
US8067071B2 (en) * 2005-07-29 2011-11-29 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
US8048500B2 (en) 2005-07-29 2011-11-01 Gore Enterprise Holdings, Inc. Composite self-cohered web materials
US8048503B2 (en) 2005-07-29 2011-11-01 Gore Enterprise Holdings, Inc. Highly porous self-cohered web materials
US8597745B2 (en) 2005-07-29 2013-12-03 W. L. Gore & Associates, Inc. Composite self-cohered web materials
US8377241B2 (en) 2005-07-29 2013-02-19 W. L. Gore & Associates, Inc. Method of making porous self-cohered web materials
US9248034B2 (en) 2005-08-23 2016-02-02 Advanced Cardiovascular Systems, Inc. Controlled disintegrating implantable medical devices
US9532888B2 (en) 2006-01-04 2017-01-03 Abbott Cardiovascular Systems Inc. Stents with radiopaque markers
US9694116B2 (en) 2006-05-26 2017-07-04 Abbott Cardiovascular Systems Inc. Stents with radiopaque markers
US9038260B2 (en) 2006-05-26 2015-05-26 Abbott Cardiovascular Systems Inc. Stent with radiopaque markers
US9358325B2 (en) 2006-05-26 2016-06-07 Abbott Cardiovascular Systems Inc. Stents with radiopaque markers
US8925177B2 (en) 2006-06-19 2015-01-06 Abbott Cardiovascular Systems Inc. Methods for improving stent retention on a balloon catheter
US9579225B2 (en) 2006-06-19 2017-02-28 Abbott Cardiovascular Systems Inc. Methods for improving stent retention on a balloon catheter
US9259341B2 (en) 2006-06-19 2016-02-16 Abbott Cardiovascular Systems Inc. Methods for improving stent retention on a balloon catheter
US9072820B2 (en) 2006-06-26 2015-07-07 Advanced Cardiovascular Systems, Inc. Polymer composite stent with polymer particles
US9173733B1 (en) 2006-08-21 2015-11-03 Abbott Cardiovascular Systems Inc. Tracheobronchial implantable medical device and methods of use
US9833342B2 (en) 2006-08-21 2017-12-05 Abbott Cardiovascular Systems Inc. Tracheobronchial implantable medical device and methods of use
US7942104B2 (en) 2007-01-22 2011-05-17 Nuvasive, Inc. 3-dimensional embroidery structures via tension shaping
US7946236B2 (en) 2007-01-31 2011-05-24 Nuvasive, Inc. Using zigzags to create three-dimensional embroidered structures
US8574611B2 (en) 2007-07-12 2013-11-05 Straumann Holding Ag Composite bone repair material
US9072586B2 (en) 2008-10-03 2015-07-07 C.R. Bard, Inc. Implantable prosthesis
US9763818B2 (en) 2010-01-30 2017-09-19 Abbott Cardiovascular Systems Inc. Method of crimping stent on catheter delivery assembly
US9770351B2 (en) 2010-01-30 2017-09-26 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US9198785B2 (en) 2010-01-30 2015-12-01 Abbott Cardiovascular Systems Inc. Crush recoverable polymer scaffolds
US9867728B2 (en) 2010-01-30 2018-01-16 Abbott Cardiovascular Systems Inc. Method of making a stent
US9827119B2 (en) 2010-01-30 2017-11-28 Abbott Cardiovascular Systems Inc. Polymer scaffolds having a low crossing profile
US8273010B2 (en) 2010-06-14 2012-09-25 Coloplast A/S Incontinence treatment device
US8550979B2 (en) 2010-06-15 2013-10-08 Coloplast A/S Method of treating incontinence
US9724198B2 (en) 2014-07-17 2017-08-08 Poriferous, LLC Orbital floor sheet
WO2016011369A1 (en) * 2014-07-17 2016-01-21 Poriferous, LLC Orbital floor sheet
WO2016019404A1 (en) * 2014-08-05 2016-02-11 Dietmar Sonnleitner Method for producing a multilayer film

Also Published As

Publication number Publication date Type
JPH06506366A (en) 1994-07-21 application
CA2094908C (en) 2000-02-08 grant
EP0560934A1 (en) 1993-09-22 application
EP0560934B2 (en) 1999-11-10 grant
DE69121587T3 (en) 2000-05-31 grant
DE69121587T2 (en) 1997-03-27 grant
CA2094908A1 (en) 1992-06-07 application
EP0560934B1 (en) 1996-08-21 grant
DE69121587D1 (en) 1996-09-26 grant
US6031148A (en) 2000-02-29 grant

Similar Documents

Publication Publication Date Title
Klinge et al. Influence of polyglactin-coating on functional and morphological parameters of polypropylene-mesh modifications for abdominal wall repair
US5152781A (en) Medical devices fabricated from homopolymers and copolymers having recurring carbonate units
Lekovic et al. Preservation of alveolar bone in extraction sockets using bioabsorbable membranes
ADLER An evaluation of surgical mesh in the repair of hernias and tissue defects
US5486593A (en) Medical devices fabricated from copolymers having recurring carbonate units
US4033938A (en) Polymers of unsymmetrically substituted 1,4-dioxane-2,5-diones
US3903882A (en) Composite dressing
Hulbert et al. History of bioceramics
US4916193A (en) Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US8197837B2 (en) Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
US5147399A (en) Method of treating nerve defects through use of a bioabsorbable surgical device
Kellomäki et al. Bioabsorbable scaffolds for guided bone regeneration and generation
US6319264B1 (en) Hernia mesh
US5066772A (en) Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
Von Arx et al. Membrane durability and tissue response of different bioresorbable barrier membranes: a histologic study in the rabbit calvarium.
US5380328A (en) Composite perforated implant structures
US5425766A (en) Resorbable prosthesis
US7329271B2 (en) High strength suture with absorbable core
US5948020A (en) Implantable bioresorbable membrane and method for the preparation thereof
EP0895762B1 (en) Bioabsorbable implantable stent with reservoir and process for fabricating the same
US5185408A (en) Medical devices fabricated totally or in part from copolymers of recurring units derived from cyclic carbonates and lactides
US7659219B2 (en) Highly porous self-cohered web materials having haemostatic properties
Hulbert et al. Tissue reaction to three ceramics of porous and non‐porous structures
US20030114937A1 (en) Biodegradable polymeric film
US6989034B2 (en) Attachment of absorbable tissue scaffolds to fixation devices

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase in:

Ref country code: CA

Ref document number: 2094908

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2094908

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1992902824

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992902824

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 1992902824

Country of ref document: EP